SGX welcomes Acromec to Catalist
Acromec is a Singapore-based company that specialises in the design and construction of facilities requiring controlled environments, such as laboratories, medical and sterile facilities and cleanrooms. The company primarily serves the healthcare, biomedical, research and academia, and electronics sectors, and counts Singapore General Hospital, Agency for Science, Technology and Research (A*STAR), National University of Singapore, Procter & Gamble and Johnson Matthey Singapore, amongst its clients.
Lim Say Chin, Executive Chairman and Managing Director of Acromec, said: “With two decades of experience in the provision of integrated specialist engineering solutions within controlled environments, Acromec has built up an established track record in Singapore. Our listing on the Catalist is timely, planned at a time when we are forging ahead with strategies to scale up our operations in Singapore and also expand our horizons into the emerging ASEAN region.”
Mohamed Nasser Ismail, Head of Equity Capital Market (SME) and Head of Capital Market Development, SGX, said, “We are delighted to welcome Acromec, an established home grown engineering services provider to Catalist, our listing platform for growth companies. We are also pleased to note that Acromec is the first company to have benefited from SGX’s collaboration with SPRING Singapore to strengthen small and medium-sized enterprises’ financial management capabilities through the SPRING Capability Development Grant. We will continue supporting the company on its growth plans.”
The listing of Acromec brings the total number of companies on Catalist to 178, with a combined market capitalisation of S\\$9 billion.
Acromec opened at \\$0.25 today.